Home Cosmetic Science Talk Formulating Stability Regulations - US

  • Stability Regulations - US

    Posted by LisaS on May 21, 2020 at 1:10 pm

    Hi all, I am reading the ICH Q1A (R2), and the way that I am reading this [bc of the scope] is that it applies specifically to NDA drug products, no necessarily monographed drug products (MDPs), but can be used where there are gaps in regulation for MDPs. It looks like 21CFR211.137 & 166 as well as the FDA’s technical guide to stability for drug products are more geared toward MDPs specifically. Or am I totally incorrect and have to follow the ICH for both MDP and NDAs? Thank you for your help!

    LisaS replied 3 years, 11 months ago 1 Member · 0 Replies
  • 0 Replies

Sorry, there were no replies found.

Log in to reply.